跳至主要内容
临床试验/JPRN-UMIN000047574
JPRN-UMIN000047574尚未招募未知

An observational study to explore the effects of anamorelin on gut microbiota in patients with carcinoma in situ with cachexia - ACADEMIC study

Cancer Treament Center, Kansai Medical University Hospital0 个研究点目标入组 40 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with a prognosis of 12 weeks or less Previous anamorelin administration Patients with concomitant severe cardiac disease Hepatic dysfunction (Child-Pugh B or C) Difficulty with oral intake due to organic abnormalities (e.g. obstruction) of the gastrointestinal tract Other patients who are deemed inappropriate by the principal investigator

研究者

发起方
Cancer Treament Center, Kansai Medical University Hospital

相似试验